decrease in all-cause mortality when patients reach goal-dose therapy within two weeks of discharge.
STRONG-HF · Mebazaa et al., Lancet 2022
--bg on [data-img-slot="hero-bg"] with your photo. Suggested: warm, human, at-home moment.
Nava Care is the AI-powered care team closing the gap between diagnosis and life-saving therapy.
Meet Arthur“I just want to walk my dog without losing my breath. I want to be there for my granddaughter's graduation.”
Reduces the heart's workload.
Slows the heart, improves survival.
Prevents fluid buildup.
Stabilizes the heart.
decrease in all-cause mortality when patients reach goal-dose therapy within two weeks of discharge.
STRONG-HF · Mebazaa et al., Lancet 2022
of heart failure patients are getting all four at the right doses.
Brownell 2021, Cardiac Failure Review
This is not a life science problem.
It's a care delivery problem.
A composite patient, drawn from our clinical experience, literature and conversations with our launch partner's cardiology team.
The doctor said I had an issue with my heart. He never said heart failure. He never said one in three. He never said there were four medicines that could change everything. That I was only started on two of the four medications I needed.
I figured if it was serious, he would've told me.
They sent me home with two new pills. After a week, one of them made me dizzy. I'm 74. I can't fall.
So I cut it in half. Then I stopped it. I never told anyone. The appointment to discuss it was three months out.
I gained fifteen pounds and didn't know it. I don't own a scale.
I started sleeping on three pillows so I could breathe. Walking to the mailbox left me winded. I told myself I was just getting old.
One night I couldn't catch my breath. My daughter called 911. They pulled fluid out of my lungs.
The hospital sent me home with more prescriptions. They still didn't say it was heart failure. I missed our family cruise.
heart failure patients die within a year under usual care.
Jackson 2018 Circ Heart Fail; Kittipibul 2024 JACC HF.
“No one told me I had a disease deadlier than some of the worst cancers. No one told me I had agency to dramatically improve my chances with the right care.”
— Arthur, 74
Built to help Arthur not only survive but thrive.
A nurse practitioner called me a few days after my diagnosis. She didn't read off a chart.
She asked me what I wanted to be doing a year from now. I told her: walking my dog. Watching my granddaughter graduate. She wrote it down.
She actually said it: I have heart failure. Then she walked me through each of the four medicines. What it does. Why I need it.
She said the dizziness on day six is normal. We'll work through it together. We won't stop.
They mailed me a scale and a blood pressure cuff. Both connect on their own.
Some days I get a text. Some days a call. I've never gone a week without hearing from them. They watch over me, and are always in reach.
One Tuesday I gained four pounds in three days. They saw it before I did. By Wednesday morning my NP had adjusted my diuretic. By Thursday I felt better.
No ambulance. No ER. No missed cruise.
“The system barely kept me alive.
Nava Care helps me live.”
— Arthur, 74
Covered by insurance.
A nurse practitioner that Arthur trusts, who is available when needed.
Daily check-ins on weight, blood pressure, and symptoms. No app gymnastics.
Works with Arthur's cardiologist. EMR-integrated. No new workflows.
The team is one text or call away.
Agents surface early warning signals so NPs intervene before the storm hits.
Existing fee-for-service (FFS) codes make it budget-neutral for health system customer from day one. Performance bonuses on avoided admissions stack on top of a falling AI cost-to-serve curve.
$0M+
Projected revenue run rate for initial launch markets.
$10M+ opportunity across all markets
$0B
TAM for first Heart Failure use-case alone, growing 13%+ annually.
Budget-neutral to implement from day one.
CEO
CPO
CTO
SAFE, on top of $400K already committed by our strategic launch partner.
A 24-month runway to enroll 1,500+ patients, hit a $3M+ annual revenue run rate, and prove the clinical and economic case to every payer and health system in the country.
Learn moreWe're closing the gap between what works and what reaches patients.